Advertisement
Screener

ARMATA PHARMACEUTICALS, INC. (ARMP) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ARMATA PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ARMATA PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $25.76M went out.
  • Fiscal year ended 2025-12-31: from investing, $542.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $25.61M came in.
  • Fiscal year ended 2025-12-31: change in cash, $693.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDividendsStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$25.76M-$542.00K-$46.00K$25.66M*-$693.00K
2024-12-31-$37.55M-$1.88M-$61.00K$35.02M*-$4.47M
2023-12-31-$47.42M-$8.13M-$43.00K$54.03M*-$1.57M
2022-12-31-$32.48M-$2.21M$44.39M$9.32M
2021-12-31-$23.57M-$1.30M$26.32M-$1.41M$613.00K*$639.00K
2020-12-31-$18.27M-$824.00K$22.89M-$568.00K*$4.12M
2019-12-31-$15.58M$2.88M$9.97M-$1.00M-$3.73M
2018-12-31-$10.63M$8.81M$12.45M*-$1.81M
2017-12-31-$9.19M-$58.00K$8.67M*-$579.00K
2016-12-31-$10.61M-$279.00K-$80.00K$7.31M*-$3.66M
2015-12-31-$9.78M-$210.00K$12.78M*$2.79M
2014-12-31-$12.57M-$1.20M-$13.77M
2013-12-31-$6.29M-$102.00K$16.89M$9.00M*$19.49M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$8.67M*-$17.00K*$0.00*$27.88M*
2026-03-31-$5.78M-$63.00K-$63.00K$704.00K*-$5.20M
2025-12-31-$6.67M*-$52.00K*$0.00*$658.00K*
2025-09-30-$4.30M*-$242.00K*-$32.00K*$15.00M*
2025-06-30-$7.21M*-$149.00K*$0.00*
2025-03-31-$7.58M-$99.00K-$14.00K$10.00M*$2.31M
2024-12-31-$7.93M*$77.00K*$0.00*
2024-09-30-$8.86M*-$340.00K*
2024-06-30-$10.18M*-$1.37M*
2024-03-31-$10.58M-$250.00K$34.93M*$24.10M
2023-12-31-$8.11M*-$2.39M*
2023-09-30-$9.69M*-$3.51M*$24.80M*
2023-06-30-$12.06M*-$222.00K*
2023-03-31-$17.57M-$2.01M$29.59M*$10.01M
2022-12-31-$10.48M*$455.00K*$0.00*-$500.00K*
2022-09-30-$10.33M*-$1.29M*-$23.00K*
2022-06-30-$8.15M*-$1.14M*-$217.00K*
2022-03-31-$3.52M-$236.00K$44.63M$40.88M
2021-12-31-$8.60M*-$228.00K*$6.96M*$0.00*
2021-09-30-$4.96M*-$582.00K*$0.00*$0.00*
2021-06-30-$4.54M*-$196.00K*-$185.00K*$0.00*
2021-03-31-$5.47M-$298.00K$19.55M-$1.41M$12.81M
2020-12-31-$6.30M*-$366.00K*$0.00*$432.00K*
2020-09-30-$3.88M*-$81.00K*-$26.00K*$0.00*
2020-06-30-$3.86M*-$273.00K*-$412.00K*$0.00*
2020-03-31-$4.23M-$104.00K$23.33M-$1.00M$18.08M
2019-12-31-$2.73M*$72.00K*$0.00*$0.00*
2019-09-30-$4.57M*$65.00K*$0.00*$0.00*
2019-06-30-$5.83M*$2.88M*$0.00*$9.97M*
2019-03-31-$2.46M-$142.00K-$1.00M-$3.60M
2018-12-31-$3.19M*-$535.00K*$6.09M*$3.66M*
2018-09-30-$2.02M*-$11.00K*-$1.30M*
2018-06-30-$1.88M*-$2.41M*
2018-03-31-$3.54M$6.61M*$3.07M
2017-12-31-$2.37M*-$18.00K*-$2.59M*
2017-09-30-$593.00K*-$33.00K*-$611.00K*-$1.24M*
2017-06-30-$2.93M*-$2.00K*$9.69M*$6.76M*
2017-03-31-$3.30M-$5.00K-$3.51M
2016-12-31-$1.48M*-$13.00K*$0.00*$3.24M*$1.74M*
2016-09-30-$3.13M*-$29.00K*-$17.00K*$0.00*-$3.18M*
2016-06-30-$2.89M*-$125.00K*$971.00K*
2016-03-31-$3.08M-$112.00K-$3.20M
2015-12-31-$2.32M*-$50.00K*-$2.37M*
2015-09-30-$2.50M*-$116.00K*$0.00*-$2.61M*
2015-06-30-$2.66M*-$9.00K*-$2.27M*
2015-03-31-$2.31M-$35.00K$12.38M*$10.04M
2014-12-31-$3.20M*-$5.00K*-$3.21M*
2014-09-30-$2.63M*-$137.00K*-$2.76M*
2014-06-30-$3.05M*-$831.00K*-$3.88M*
2014-03-31-$3.69M-$229.00K$0.00-$3.92M
2013-12-31-$1.41M*-$5.00K*$16.91M*$15.50M*
2013-09-30-$2.49M*-$32.00K*-$2.53M*
2013-06-30-$1.27M*-$65.00K*$8.00M*$6.67M*
2013-03-31-$1.12M$0.00$0.00$976.00K*-$143.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22